| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head of Pharm Ops and Tech
1 company
Murphy Nicole is a Head of Pharm Ops and Tech at BIIB. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $3.8M at current prices.
Murphy Nicole's largest disclosed position is in BIIB as Head of Pharm Ops and Tech, worth about $3.8M. Net of sales, the recent Form 4 record there shows accumulation of 3 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | BIIB Biogen Inc. | Head of Pharm Ops and Tech | Buy | 3 | $195.04 | $585.11 | - | +4.6% | - |